Table 4.
Percutaneous CathLab interventions and related procedures in Austria (2012–2017)
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Rotablator | 312 | 369 | 418 | 373 | 312 | 300 |
| Catheter thrombectomy (clot catcher/remover) | 1848 | 1799 | 1606 | 1317 | 1077 | 891 ↓ |
| Intracoronary pressure registration (“fractional flow reserve” (FFR)) | 2182 | 2547 | 2524 | 3153 | 3631 | 3668 |
| FFR decision with adenosine and/or | – | – | – | – | 3220 | 3164 ↓ |
| FFR decision without adenosine (= iFR) | – | – | 19 | 64 | 411 | 604 ↑ |
| PCI for chronic total occlusion (CTO) | 637 | 589 | 559 | 790 | 782 | 808 |
| Intracoronary ultrasound (IVUS) | 816 | 783 | 711 | 670 | 808 | 755 |
| Intra-aortic balloon pump during PCI | 121 | 87 | 82 | 69 | 37 | 53 ↑ |
| Other devices (e.g. mechanical circulation support,, protection device) in PCI | 53 | 22 | 118 | 102 | 18 | 30 ↑ |
| Platelet glycoprotein IIb/IIIa antagonist | 2025 | 1775 | 1815 | 1597 | 1467 | 1201 ↓ |
| Direct thrombin inhibitor in PCI | 1110 | 1277 | 1406 | 858 | 439 | 198 ↓ |
| Optical coherence tomography (OCT) | 350 | 570 | 503 | 580 | 707 | 638 |
| Alcohol ablation for septal hypertrophy (PTSMA) | 8 | 14 | 11 | 6 | 13 | 9 |
Special techniques, Original questionnaire of the European Society of Cardiology (ESC) [19]
cases; n pooled analysis
Striking differences in italics. Striking changes from 2016 to 2017 are indicated with directional arrows ↑ (increase) ↓ (decrease)
“–” data not available
PCI percutaneous coronary intervention